Introduction to the Emerging Health Issue


Develop a 30-minute presentation that addresses an emerging health issue relevant to population health.

The presentation should include the following components:

Introduction to the Emerging Health Issue:

Clearly define the emerging health issue and provide background information, including its significance and impact on population health. Use epidemiological data to highlight trends and affected demographics.
Evaluation of Organizational and Fiscal Factors:

Analyze how organizational structures and fiscal considerations influence the response to the emerging health issue. Discuss any challenges faced by healthcare organizations in addressing this issue and how resource allocation impacts health outcomes. 
Policy Analysis:

Evaluate existing policies related to the emerging health issue. Analyze their effectiveness and identify gaps or areas for improvement. Provide evidence-based recommendations for policy changes that could enhance population health outcomes. 
Advocacy Strategy:

Develop a strategic advocacy plan aimed at influencing policy changes. Identify key stakeholders, define clear objectives, and outline engagement strategies. Craft persuasive messages to communicate the importance of your recommendations.

 

Sample Answer

 

 

 

 

 

 

Title: The Silent Surge: Addressing the Crisis of "Long COVID" and Post-Viral Sequelae in Population Health

I. Introduction to the Emerging Health Issue (5 Minutes)

Definition: Post-Acute Sequelae of SARS-CoV-2 (PASC), commonly known as Long COVID, is defined as persistent symptoms lasting more than 4 weeks after initial infection that cannot be explained by an alternative diagnosis.

Significance: It is a "mass disabling event." Unlike the acute phase, Long COVID affects multiple organ systems, including the neurological, cardiovascular, and endocrine systems.

Epidemiological Trends:

Prevalence: According to CDC data (2024-2025), approximately 5.3% of all U.S. adults report current Long COVID symptoms.

Demographics: The highest incidence is found in adults aged 35–54, a critical demographic for the workforce and caregiving.

Disparities: Significant prevalence is noted in Hispanic and LGBTQ+ populations, often exacerbated by lack of initial access to acute-phase treatments.